Ewing’s sarcoma is a rare tumor that develops in children, teens, and young adults. The month of July is devoted to increasing awareness of sarcoma. Find out how to get involved. Share on Pinterest ...

Osteosarcoma and Ewing sarcoma are two types of bone cancer primarily affecting children and young adults. While both types of cancer originate in bone tissue, their symptoms, treatment, and location ...

Ewing sarcoma develops due to genetic causes that include changes to a person’s DNA and chromosomes. It more often affects teenagers and young adults, males, and white people. The exact cause of Ewing ...

Ewing sarcoma is a rare and serious diagnosis, largely impacting children. The disease only accounts for about 1% of all pediatric cancers in the U.S., with about 250 children diagnosed every year, ...

Childhood cancer is the No. 1 disease-related cause of death among children in the United States, with one in six young patients not surviving. For families grappling with a cancer diagnosis, the ...

Ewing sarcoma bone tumors have an onion-skin appearance on imaging scans. This happens because the tumors stimulate the growth of a membrane that surrounds the bones. Ewing sarcoma is a bone cancer ...

A research consortium made up of the Virgen del Rocio hospital in Seville, Sant Joan de Deu and the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona, has found a new therapeutic ...

Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) extended the lives of a small group of kids with ...

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL), led by Oscar Martínez Tirado participated in an international study which suggests inhibition of Sirtuin1 (SIRT1) protein as a ...

Belleville teen Richard Mothersell battles rare dual cancers Ewing sarcoma and AML, inspiring a community to support his ...

A phase 1/2 trial evaluating seclidemstat plus Vidaza resumed patient enrollment for those with certain blood cancers and another phase 1/2 trial demonstrated improved results in patients with Ewing ...